Excitatory amino acid receptor antagonists decrease hypoxia induced increase in extracellular dopamine in striatum of newborn piglets

Neurochemistry International

Volumn 32, Issue 3, 1998, Pages 281-289

  Kuo, Meng Fai ^a   Song, Dekun ^a   Murphy, Stephanie ^a   Delivoria Papadopoulos, Maria ^a   Wilson, David F ^a   Pastuszko, Anna ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMINO ACID RECEPTOR BLOCKING AGENT; DIZOCILPINE; DOPAMINE; EXCITATORY AMINO ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RINGER SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN OXYGEN TENSION; BRAIN PERFUSION; CONTROLLED STUDY; CORPUS STRIATUM; HYPOXIA; MICRODIALYSIS; NEUROPROTECTION; NEWBORN; NONHUMAN; PHOSPHORESCENCE; PRIORITY JOURNAL; SWINE;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; CORPUS STRIATUM; DIZOCILPINE MALEATE; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; EXTRACELLULAR SPACE; OXYGEN; OXYGEN CONSUMPTION; PRESSURE; QUINOXALINES; RECEPTORS, AMINO ACID; SWINE;

ANIMALIA; SUS SCROFA;

EID: 0032033528     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(97)00091-0     Document Type: Article

References (96)

1. Akiyama, Y., Ito, A., Koshimuru, K., Ohue, T., Yamagata, S., Miwa. S., & Kikuchi, H. (1991a). Effects of transient forebrain ischemia and reperfusion on function of dopaminergic neurons and dopamine reuptake in vivo in rat striatum. Brain Research, 561, 120-127.
2. Akiyama, Y., Koshimura, K., Ohue, T., Lee, K.. Miwa, S., Yamagata, S.. & Kikuchi, H. (1991b). Effects of hypoxia on the activity of the dopaminergic neuron system as studied by in vivo brain microdialysis. J. Neurochem.. 57, 997-1002.
3. Adachi-Akuhane, S., Amano, Y., Okuyama, R., & Nagao, T. (1993). Quaternary diltiazem can act from both sides of the membrane in ventricular myocytes. Jap. J. Pharmac., 61, 263-266.
4. Albin, R, L.. Makowiec, R. L., Holtingsworth, Z. R., Dure, L. S., Penney, J. B., & Young A. B. (1992). Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience, 46, 35-48.
5. Bielenberg, G. W. (1988). Infarct reduction by NMDA antagonists in a rat stroke model. In: Pharmacology of Cerebral Ischemia, ed. J. Krieglstein. pp. 239-242. CRC Press, Boca Raton, Florida.
6. Benveniste, H., Drejer, J., Schousboe, A., & Diemer, N. H. (1984). Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient ischemia monitored by intracerebral dialysis. J. Neurochem., 43, 1369-1374.
7. Bowyer, J. F., Gough, B., Broening, H. W., Newport, G. D., & Schued, L. (1993). Fluoro-gold and pentamidine inhibit the in vitro and in vivo release of dopamine in the striatum of rat. J. Pharm. Exper. Therap., 266, 1066-1074.
8. +H] dopamine release from striatal slices. J. Pharmacol. Exp. Ther., 261, 72-80.
9. Brooks, K. J , & Kauppinen, R. A. (1993). Calcium mediated damage following hypoxia in cerebral cortex ex vivo studied by NMR spectroscopy. Evidence for direct involvement of voltage gated Ca channels. Neurochem Int., 23, 441-450.
10. Buchan, A., Li, H., & Pulsinelli, W. A. (1991). The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats. J. Neurosci., 11, 1049-1056.
11. Buchan, A., & Pulsinelli, W. A. (1990). Hypothermia but not N-methyl-D-aspartate antagonist MK-801, attenutes neuronal damage in gerbils subjected to transient global ischemia. J. Neurosci., 10, 311-316.
12. Buisson, A., Callebert, J., Mathieu, E., Plotkine, M., & Boula, R. G. (1992). Striatal protection induced by lesioning the substantia nigra of rats subjected to focal ischemia. J. Neurochem., 59, 1153-1157.
13. Cai, N., Kiss, B., & Erdo, S. L. (1991). Heterogeneity of N-methyl-D-aspartate receptors regulating the release of dopamine and acetylcholine from striatal slices. J. Neurochem., 57, 2148 -2151.
14. Carrozza, D. P., Ferraro, T. N., Golden, G. T., Reyes, P. F., & Hare, T. A. (1992). In vivo modulation of excitatory amino acid receptors: microdialysis studies on N-methyl-D-aspartate evoked striatal dopamine release and effects of antagonists. Brain Res., 574, 42-48.
15. Carter, C. J., L'Heureux, R., & Scatton, B. (1988). Differential control by N-methyl-D-aspartate and kainate of striatal dopamine release in vivo: a trans-striatal dialysis study. J. Neurochem., 51, 462-468.
16. Chang, C. J., Ishii, H., Yamamoto, T., & Spatz, M. (1993). Effects of cerebral ischemia on regional dopamine release and D1 and D2 receptors. J. Neurochem, 60, 1483-1490.
17. Chapman, A. G., Durmuller, N., Lee, G. J., & Meldrum, B. S. (1989). Excitotoxicity of NMDA and kainic acid is modulated by nigrostnatal dopaminergic fibers. Neurosci. Lett., 107, 256-260.
18. Chapman, A. G., Engelsen, B., & Meldrum, B. (1987). 2-amino-7-phosphonoheptanoic acid inhibits insulin-induced convulsions and striatal aspartate accumulation in rats with frontal cortical ablation. J. Neurochem., 49, 121-127.
19. Cheramy, A., Romo, R., Godeheu, G., Baruch, P., & Glowinski, J. (1986). In vivo presynaptic control of dopamine release in the cat caudate nucleus-II. Facilitory or inhibitory influence of L-glutamate. Neuroscience, 19, 1081-1090.
20. Choi, D. W. (1988), Glutamate neurotoxicity and diseases of the nervous system. Neuron, 1, 623-634.
21. Choi, D. W. (1990). Cerebral hypoxia: some new approaches and unanswered questions. J. Neuroscience, 10, 2493-2501.
22. Choi, D. W. (1992). NMDA receptors, AMPA receptors, and extracellular acidity in ischemic brain damage: a view from the dish. In Pharmacology of Cerebral Ischemia, eds J. Kriegkstein and H. Oberpichler-Schwenk. pp 45-52. Wissenschaftliche Verlagsgesellschaft, Stuttgart.
23. Clemens, J. A., & Phebus, L. A. (1987). Dopamine depletion protects striatal neurons from ischemia induced cell death. Life Sci., 42, 707-713.
24. Clifford, D. B., Olney, J. W., Benz, A. M., Fuller, T. A., & Zorumski, C. F. (1990). Ketamine. phencyclidine and MK-801 protect against kainic acid-induced seizure related brain damage. Epilepsia, 31, 382-390.
25. Clow, D. W., & Jhamandas, K. (1988). Characterization of L-glatamate action on the release of endogenous dopamine from rat caudate-putamen. J. Pharmacol. Exp. Ther., 248, 722-728.
26. Desce, J. M., Godeheu, G., Cheremy, A., & Glowinski, J. (1991). Presynaptic regulation of dopamine release from synaptosomes of rat striatum is controlled by different types of glutamate receptors. Adv. Biosci., 82, 95-96.
27. Desce, J. M., Godeheu, G., Galli, T., Artaud, F., Cheremy, A., & Glowinski, J. (1992). E-glutamale evoked release of dopamine from synaptosomes of the rat striatum: involvement of AMPA and N-methyl-D-aspartate receptors. Neuroscience, 47, 333-339.
28. Diemer, N. H., Jorgensen, M. B., Johansen, F. F., Sheardoun, M., & Honore T. (1992). Protection against ischaemic hippocampal CAJ damage in the rat with a new non-NMDA antagonist, NBQX. Acta Neurol. Scand., 86, 45-49.
29. Germano, I. M., Pitts, L. H., Meldrum, B. S., Bartkowski, H. M., & Simon, R. P. (1987). Kynurenate inhibition of cell excitation decreases stroke size and deficits. Ann. Neurol., 22, 730-734.
30. Giorguieff, M. F., Kemel, M. L., & Glowinski, J. (1977) Presynaptic effect of L-glutamic acid on the release of dopamine in rat striatal slices. Neurosci. Lett., 6, 73-77.
31. Gill, R., Foster, A. C., & Woodruff, G. N. (1988). MK-801 is neuroprotective in gerbils when administered at the post-iscbemic period. Neurosci., 25, 847-854.
32. Gill, R., Nordholm, L., & Lodge, D. (1992). The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model. Brain Res., 580, 35-43.
33. Globus, M. Y-T., Busto, R., Dietrich, W. D., Martinez, E., Valdes, I., & Ginsberg, M. D. (1988). Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and γ-aminobutyric acid studied by intracerebral microdialysis. J. Neurnchem., 51, 1455-1464.
34. Goldberg, M. P., Weiss, J. H., Pham, P. C., & Choi, D. W. (1987). N-metyl-D-aspartate receptors mediate hypoxic neuronal injury in cortical culture. J. Pharmacol. Exp. Ther., 243, 784-791.
35. Gotti, B., Duverger, D., Bertin, J., Carter, C., Dupont, R., Frost, J., Gaudilliere, B., MacKenzie, E. T., Rousseau, J., Scatton, B., & Wick, A. (1988). Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. 1. Evidence for efficacy in models of focal cerebral ischemia. J. Pharmac. Exp. Ther., 247, 1211-1221
36. Graham, D. T. (1984). Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. Neurotoxicology, 5, 83-96.
37. Hallgren, B., & Sourander, P. (1958). The effect of age on the nonhaemin iron in the human brain. J. Neurochem., 3, 41-51.
38. Hassler, R., Haug, P., Nitsch, C., Kim, J. S., & Palk, K. (1982). Effect of motor and premotor cortex ablation on concentrations of amino acids, monoamines and acetylcholine and on the ultrastructure in rat striatum. A conformation of glutamate as the specific corticostriatal transmitter. J. Neurochem., 38, 1087-1098.
39. Hillered, L., Hallstrom, A., Segersvard, S., Persson, L., & Ungerstedt, U. (1989). Dynamics of extracellular metabolises in the striatum after middle cerebral artery occlusion in the rat monitored by intracerebral microdialysis. J. Cereb. Blood Flow and Metab., 9, 607-616.
40. Hoffman, D. J., McGowan, J. E., Marro P. J., Mishra, O. P., & Delivoria-Papadopoulos, M. (1994). Hypoxia-induced modification of the N-methyl-D-aspartate receptor in the brain of the newborn piglet. Neurosci. Lett., 167, 156-160.
41. Huang, Ch-Ch., Lajevardi, N. S., Tammela, O., Pastuszko, A., Delivoria-Papadopoulos, M., & Wilson, D. F. (1994). Relationship of extracellular dopamine in striatum of newborn piglets to cortical oxygen pressure. Neurochem. Res., 19, 649-655.
42. Imperato, A., Honore, T., & Jensen, L. H. (1990). Dopamme release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely moving rats. Brain Res., 530, 223-228.
43. Iravani, M. M., & Kruk, Z. L. (1996). Real-time effects of N-methyl-D-aspartic acid on dopamine release in slices of rat caudate putamen: a study using fast cyclic voltammetry. J Neurochem., 66, 1076-1085.
44. Jacocks III., H. M., Izenwasser, S., Werline, L. L., & Cox, B. M. (1991). Comparison of dopamine uptake and release in vitro in sheep and rat striatum. Life Sci., 49, 481-488.
45. Jedema, H. P., & Moghaddam, B. (1996). Characterization of excitatory amini acid modulation of dopamine release in the prefronlal cortex of conscious rats. J. Neurochem., 66, 1448-1453.
46. 3H] norepinephrine release. J. Pharmacol. Exp. Ther., 240, 492-497.
47. Katai, S. T., Kocsis, J. D., Preston, R. J., & Sugimori, M. (1976). Monosynaptic inputs to caudate nucleus identified by intracellular injection of horseradish peroxidase. Brian Res., 109, 601-606.
48. Keefe, K. A., Zigmond, M. J., & Abercrombie, E. D. (1992). Extracellular dopamine in striatum: influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input. Neuroscience, 47, 325-332.
49. Kemel, M. L., Desban, M., Glowinski, J., & Gauchy, C. (1989). Distinct presynaptic control of dopamine release in striosomal and matrix areas of cat caudate nucleus. Proc. Acad. Sci. U.S.A.. 86, 9006-9010.
50. Knapp, A. G., & Dowling, J. E. (1987). Dopamine enhances excitatory amino acid gated conductances in cultured retinal horizontal cells. Nature, 325, 437-439.
51. Krebs, M. O., Kemel, M. L., Gauchy, C., Desban, M., & Glowinski, J. (1989). Glycine potentiates the NMDA induced release of dopamine through a strychnine insensitive site in the rat striatum. Eur. J. Pharmacol., 166, 567-570.
52. Krebs, M. O., Desce, J., Kemel, M. L., Gauchy, C. Cheramy, A., & Glowinski, J. (1991). Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem., 56. 81 85.
53. Krebs, M. O., Trovero, F., Desban, M., Gauchy, C. Glowinski, J., & Kemel, M. L. (1991a). Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome- and matrix-enriched areas of rat striatum. J. Neurochem., 11, 1256-1262.
54. Leviel, V., Gobert, A., & Guihert, B. (1990). The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function. Neuroscience, 39, 305-312.
55. MacDermott, A. B., & Dale, N. (1987). Receptors, ion channels and synaptic potentials underlying the integrative actions of excitation amino acids. Trends Neurosci., 10, 280-284.
56. Masuda, T., Yamazaki, M., & Ito, Y. (1990). Comparison between extracellular and tissue fluctuation of dopamine and related metabolises in striatum under hypoxia. Brain Res., 523, 356-358.
57. Mayer, M. L., & Westbrook, G. L. (1987). Cellular mechanisms underlying excitotoxicity. Trends Neurosci., 10, 59-61.
58. McCulloch, J., Bullock, R., & Teasdale, G. M. (1991). Excitatory ammo acid antagonists: opportunities for the treatment of isihemic brain damage in man. In Excitatory Amino Acid Antagonists, ed. B. Meldrum, pp. 287-326. Blackwell Sci. Publ.
59. McCulloch, J., Park, C. K., Oyxurt, E., Nehls, D. G., Teasdale, G.,M., & Graham, D. I. (1988). Effects of MK-801 in experimental models of focal cerebral ischemia in the cat and rat. In Pharmacology of Cerebral Isclu'mui. ed. J. Krieglstein, pp. 173-179. CRC Press, Boca Raton. Florida.
60. McDonald, J., Silverstein, F., Cardura, D., Hudson C., Chen, R., & Johnston, M. (1990). Systemic administration of MK-801 protects against N-rnethyl-D-aspartate and quisqualate neurotoxieity in perinatal rats. Neurosci., 36, 589-599.
61. Ment, L. R., Stewart, W. B., Petroff, O. A., Duncan, C. C., & Montoya, D. (1989). Beagle puppy model of perinatal asphyxia: blockade of excitatory neurotransmitters. Pediatr. Neurol., 5, 281-286.
62. Moghaddam, B., Gruen, R. J., Roth, R. H., Bunncy, B. S., & Adams, R. N. (1990). Effect of L-glutamate on the release of siriatal dopamine: in vivo dialysis and electrochemical studies. Brain Res., 518, 55-60.
63. Nellgard, B., & Wieloch, T. (1992). Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. J. Cereb. Blood Flow Metab., 12, 2-11.
64. Nieoullon, A., Kerkenan, L., & Dusticier, N. (1982). Inhibitory effects of dopamine on high affinity glutamate uptake from rat striatum. Life Sci., 30, 1165-1172.
65. Nieoullon, A., Cheremy, A., & Glowinski, J. (1978). Release of dopamine evoked by electrical stimulation of the motor and visual areas of the cerebral cortex in both caudate nuclei and the substantia nigra in the cat. Brain Rex., 145, 69-83.
66. Olano, M., Song, D., Murphy, S., Wilson, D. F., & Pastuszko, A. (1995). Relationships of dopamine, cortical oxygen pressure, and hydroxyl radicals in brain of newborn piglets during liypoxia and post-hypoxic recovery. J. Neurochem., 65, 1205-1212.
67. Ooboshi, H., Sadoshima, S., Yao, H., Nakahara, T., Uchimura, H., & Fujishima, M. (1992). Inhibition of ischemia induced dopamine release by omega-conotoxin. a calcium channel blocker, in the striatum of spontaneously hypertensive rats: in vivo brain dialysis study. J. Neurochem., 58, 298-303.
68. Ozyurt, E., Graham, D. I , Woodruff, G. N., & McCulloch, J. (1988). Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat. J. Cereb. Blood Flow Metab., 8, 138-143.
69. Park, C. K., Nehls, D. G., Graham, D. I., Teasdale, G. M., & McCulloch J. (1988a). Focal cerebral ichernia in cat: treatment with glutamate antagonist MK-801 after induction of ischemia. J. Cereb. Blood Flow Metab., 8, 757-762.
70. Park, C. K.. Nehls, D. G., Graham, D. I., Teasdale, G. M., & McCulloch, J. (1988b). The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann. Neurol., 24, 543-551.
71. Pastuszko, A. (1994). Metabolic responses of the dopaminergic system during hypoxia in newborn brain. Biochem Med. Metab. Biol., 51, 1-15.
72. Pastuszko, A., Lajevardi, S. N., Chen, J., Tammela, O., Wilson, D. F., & Delivoria-Papadopoulos, M. (1993). Effects of graded levels of tissue oxygen pressure on dopamine metabolism in striauim of newborn piglets. J. Neurochem., 60. 161-166.
73. Pulsinelli, W. A. (1992). Pathophysiology of acute ischemic stroke. Lancet, 139, 533-536.
74. Pulsinelli, W. A., Brierley, J. B., & Plum, F. (1982). Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol., 11, 491-498.
75. 3H] dopamine from rat striatal slices Neurosci. Lett., 96, 323-328.
76. 3H]dopamine release from rat striatum: in vitro model for glutamate actions. J. Neurochem., 32, 1539-1545.
77. Roman, R., Bartkowski, H., & Simon, R. (1989). The specific NMDA receptor antagonist AP-7 attenuates focal ischemic brain injury. Neurosci. Lett., 104, 19-24.
78. Romo, R., Cheramy, A., Godeheu, G., & Glowinski, J. (1986). In vivo presynaptic control of dopamine release in the cat caudate nucleus -III. Further evidence for the implication of cortico-striatal glutamatergic neurons. Neuroscience, 19, 1091-1099.
79. Schurr, A., Payne, R. S., & Rigor, B. M. (1995). Protection by MK-801 against hypoxia-, excitotoxin- and depolarization-induced neuronal damage in vitro. Neurochem. Int., 26, 519-525.
80. Schurr, A., Payne, R. S., & Rigor, B. M. (1993). MK-801 is both an NMDA and a calcium channel blocker in hypoxic hippocampal slices. Soc. Neurosci. Abstr., 19, 1646.
81. Shapira, Y., Yadid, G., Cotev, S., Niska, A., & Shohami, E. (1990). Protective effect of MK-801 in experimental brain injury. J. Neurotrauma, 7, 131-139.
82. Sheardown, M. J., Nielson, E. O., Hansen, A. J., Jacobsen, P., & Honore, T. (1990). 2,3-Dihydroxy-6-nitro-7-sulphamoylbenzo(Fiquinoxaline: a neuroprotectant from cerebral ischemia. Science, 247, 571-574.
83. Shimizu, N., Duan, S., Hori, T., & Oomura, Y. (1990). Glutamate modulates dopamine release in the striatum as measured by brain microdialysis. Brain Res. Bull., 25, 99-102.
84. Versace, P., Boechieri, P., Marchi, M., & Raiteri, M. (1987). Intrastriatal kainic acid elicits functional supersensitivity of muscarinic receptors regulating dopamine release. Neurochem. Int., 11, 183-188.
85. Vezzani, A., Serafini, R., Stasi, M. A., Caccia, S., Conti, I., Tridico, R V., & Samanin, R. (1989). Kinetics of MK-801 and its effects on quinolinic acid-induced seizures and neurotoxicity in rats. J. Pharmac. Exp. Ther., 249, 278-283.
86. Wang, T., & French, E. D. (1993). L-Glutamate excitation of A10 dopamine neurons is preferentially mediated by activation of NMDA receptors: extra- and intra-cellular electrophysiological studies in brain slices. Brain Res., 627, 299-306.
87. Watanabe, T., Kalasz, H., Yabana, H., Kuniyasu, A., Mershon, J., Itagaki, K., Vaghy, P. L., Naito, K., Nakayama, HI., & Scrwartz, A. (1993). Azidobutyryl clentiazcin. a new photoactivalable diltiazem analog, labels benzothiazepine binding sites in the cl subunit of the skeletal muscle calcium channel. FEBS Lett., 334, 261-264.
88. Werling, L. L., Jacocks III, H. M., Rosenthal, R. E-., & Fiskum, G. (1993). Dopamine release from canine striatum following global cerebral ischemia/reperfusion. Brain Res., 606, 99-105.
89. Westerink, B. H. C., & De Vries, J. B. (1988). Characterization of in vivo dopamine release as determined by brain microdialysis after acute and subchronic implantations: methodological aspects. J. Neurochem., 51, 683-687.
90. Westerink, B. H. C., Santiago, M., & DeVries, J. B. (1992). The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat. Naunyn Schmiedebergs Arch. Pharmacol., 345, 523-529.
91. Whitton, P. S., Maione, S., Biggs, C. S., & Fowler, L. J. (1994). N-methyl-D-aspartate receptors modulate extracellular dopamine concentration and metabolism in rat hippocampus and striatum in vivo. Brain Res., 635, 312-316.
92. Wilson, D. F., Rumsey, W. L., Green, T. J., & Vanderkooi, J. M. (1988). The oxygen dependence of mitochondrial oxidative phosphorylation measured by a new optical method for measuring oxygen concentration. J. Biol. Chem., 263, 2712-2718.
93. Wilson, D. F., Pastuszko, A., DiGiacomo, J. E., Pawlowski, M., Schneiderman, R., & Delivoria-Papadopoulos, M. (1992). Effect of hyperventilation on oxygenation of the brain cortex of newborn piglets. J. App. Physiol., 70, 2691-2696.
94. Wong, E. H. F., Kemp, J. A., Priestley, T., Knight, A. R., Woodruff, G. N., & Iversen, L. L. (1986). The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Nat. Acad. Sci., 83, 7104-7108.
95. Young, A. M. J., & Bradford, H. F. (1986). Excitatory amino acid neurotransmitters in the corticostriate pathway: studies using intracerebral microdialysis in vivo. J. Neurochem., 47, 1399-1404.
96. Youngren, K. D., Daly, D. A., & Moghaddam, B. (1993). Distinct actions of endogenous excitatory amino acid on the outflow of dopamine in the nucleus accumbens. J. Pharmacol. Exp. Ther., 264, 289-293